Oncologix Tech, Inc.
OCLG
$0.0001
$0.000.00%
OTC PK
| 05/31/2016 | 05/31/2015 | ||||
|---|---|---|---|---|---|
| Net Income | -- | -119.83% | |||
| Total Depreciation and Amortization | -- | -12.28% | |||
| Total Amortization of Deferred Charges | -- | 12.02% | |||
| Total Other Non-Cash Items | -- | 134.08% | |||
| Change in Net Operating Assets | -- | 461.41% | |||
| Cash from Operations | -- | 66.51% | |||
| Capital Expenditure | -- | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -- | -- | |||
| Total Debt Issued | -- | 15.90% | |||
| Total Debt Repaid | -- | -46.54% | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | -- | -34.86% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -- | -9.50% | |||